To confirm the presence of antibodies against ACE2 in sera from patients with COVID-19, a panel of 30 commercial serum samples collected from patients with COVID-19 and 60 serum samples from normal individuals were screened for the presence of antibodies against S1-RBD and ACE2 by ELISA. The gene discussed is PSMD1; the disease is COVID-19.